Clinical Trials Browser

Phase 1/2 × Central Nervous System Neoplasms × poly ICLC × Clear all

NCT01920191 2016-04-20

Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma

Phase 1/2 Completed

Glioblastoma, Central Nervous System Neoplasms